Onvansertib Product Pipeline Pipeline Our pipeline opens many attractive opportunities for onvansertib mCRPC / Abiraterone Enrolling mPDAC / Biomarker Target Q1 '22 CMML / Single Agent Development Medulloblastoma / Combo w/ radiation Development Ovarian / PARP inhibitors Development Looking to partner with us? Please send inquiries to [email protected]